NR3C1 and triple-negative breast carcinoma: GR activation also acts via the induction of serum- and glucocorticoid-induced kinase-1 (SGK1) upregulation, which is a significant contributor to many cancers, including triple-negative breast cancer (TNBC), where it contributes to GR potentiation of metastasis and proliferation [66].